2130 participants
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-04-29
- Start Date:
- 2000-02-29
- Completion:
- 2005-03-31
Conditions
- Breast Cancer
Interventions
- BIOLOGICAL
- DRUG
No Results Yet